Oruka Therapeutics, Inc. (ORKA)
93.55
+1.35
(+1.46%)
USD |
NASDAQ |
Sep 16, 16:00
93.61
+0.06
(+0.06%)
After-Hours: 20:00
Oruka Therapeutics Debt to Equity Ratio : 0.0023 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0023 |
| March 31, 2026 | 0.0037 |
| December 31, 2025 | 0.0041 |
| September 30, 2025 | 0.0039 |
| June 30, 2025 | 0.0068 |
| March 31, 2025 | 0.0026 |
| December 31, 2024 | 0.0025 |
| September 30, 2024 | 0.0025 |
| June 30, 2024 | 0.0007 |
| March 31, 2024 | 0.0014 |
| December 31, 2023 | 0.0076 |
| September 30, 2023 | 0.0079 |
| June 30, 2023 | 0.0084 |
| March 31, 2023 | 0.0088 |
| December 31, 2022 | 0.0092 |
| September 30, 2022 | 0.0096 |
| June 30, 2022 | 0.0097 |
| March 31, 2022 | 0.0096 |
| December 31, 2021 | 0.0095 |
| September 30, 2021 | 0.009 |
| June 30, 2021 | 0.0085 |
| March 31, 2021 | 0.0068 |
| December 31, 2020 | 0.0097 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.0024 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0079 |
| December 31, 2019 | 0.0033 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Tenax Therapeutics, Inc. | 0.00 |
| Manhattan Scientifics, Inc. | -- |
| Exicure, Inc. | 0.00 |
| Century Therapeutics, Inc. | 0.1664 |
| Absci Corp. | 0.0156 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.139B |
| Total Liabilities (Quarterly) | 24.84M |
| Shareholders Equity (Quarterly) | 1.115B |
| Current Ratio | 38.51 |
| Net Debt Paydown Yield | -0.01% |